Skip to main
SYK
SYK logo

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Stryker's operating margin improved by 110 basis points year-over-year, reaching 25.7%, which was slightly above consensus expectations of 25.5%. The company's gross margin also increased by 120 basis points year-over-year, reflecting efficiencies that contributed to strong financial performance. Stryker's ongoing execution with a diverse range of new products has resulted in notable revenue growth, enhancing its competitive position in the medical equipment market.

Bears say

Stryker's stock outlook is negatively impacted by an anticipated slowdown in organic revenue growth, projected to decline to 8% or less, driven by potential failures in new product launches and revenue dis-synergies from acquisitions. The company's management highlighted challenges, including weak sales from Inari Medical and issues related to sales rep turnover and destocking, which may hinder overall performance. Additionally, risks such as slower orthopedic market growth and declining hospital capital spending contribute to concerns regarding Stryker's future earnings and profitability, which could lead to earnings dilution.

Stryker (SYK) has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 18 analysts, Stryker (SYK) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $429, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $429, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.